Are you or your loved one suffering from fatty liver disease?

You may be eligible to participate in a study for fatty liver (also known as nonalcoholic steatohepatitis (NASH) or nonalcoholic fatty liver disease) with an investigational medication.

Are you or your loved one suffering from fatty liver disease? You may be eligible to participate in a study for fatty liver (also known as nonalcoholic steatohepatitis (NASH) or nonalcoholic fatty liver disease) with an investigational medication.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Recruiting for this study? Get access to patient recruitment tools.
Fatty Liver Disease Clinical Trial in Miami FL

What you may receive

Compensation of $75-$150 per visit

Are you or your loved one suffering from fatty liver disease?

You may be eligible to participate in a study for fatty liver (also known as nonalcoholic steatohepatitis (NASH) or nonalcoholic fatty liver disease) with an investigational medication.

Are you or your loved one suffering from fatty liver disease? You may be eligible to participate in a study for fatty liver (also known as nonalcoholic steatohepatitis (NASH) or nonalcoholic fatty liver disease) with an investigational medication.

Fatty liver disease (also known as nonalcoholic steatohepatitis (NASH) or nonalcoholic fatty liver disease) is a type of liver disease that affects millions of Americans each year. These conditions can cause long lasting damage to the liver and can progress into liver failure. There are currently no FDA-approved medications for the treatment of fatty liver disease. This research study is evaluating the effectiveness of a new investigational treatment for fatty liver disease.

What's involved?

After submitting an application to participate in this research study, you will be contacted by a member of the research team. The research team will help determine your eligibility and schedule in office visits to complete the screening process. If you are eligible and choose to enroll in the study you will need to attend additional visits with the research team and follow the study protocol.

Who can participate?

You may be eligible for this study if:
-You are between the ages of 18 and 75
-You have been diagnosed with fatty liver (also known as nonalcoholic steatohepatitis (NASH) or nonalcoholic fatty liver disease)
-OR you have risk factors like high cholesterol and diabetes.
-You do not drink more than 2 alcoholic drinks per day on average?
-You do not have HIV, Hepatitis B or any other active liver disease

If you decide to apply to participate in this trial, a member of the research team will reach out to help determine your eligibility and help answer your questions about the study.

Where you'll go

Selected location

University of Miami Miller School of Medicine

University of Miami Miller School of Medicine Change

1600 Northwest 10th Avenue, Miami, FL, USA 33136
Map | Learn more
Available locations
Montefiore Medical Center

Montefiore Medical Center

Recruiting 111 East 210th Street, Bronx, NY, USA 10467

Universitätsklinikum RWTH Aachen

Universitätsklinikum RWTH Aachen

Recruiting Aachen, DEU 52074

Aarhus University Hospital

Aarhus University Hospital

Recruiting Nørrebrogade, Aarhus, DNK 8000

Southwest Gastroenterology Associates

Southwest Gastroenterology Associates

Recruiting Albuquerque, NM, USA 87109

CHU Amiens Picardie

CHU Amiens Picardie

Recruiting Place Victor Pauchet, Amiens, FRA 80054

Academisch Medisch Centrum

Academisch Medisch Centrum

Recruiting 9 Meibergdreef, Amsterdam, NLD 1105 AZ

Vrije Universiteit Medical Center

Vrije Universiteit Medical Center

Recruiting Amsterdam, NLD 1081 HZ

CHU Angers

CHU Angers

Recruiting 4 Rue Larrey, Angers, FRA 49933

Interested in participating?
Selected location

University of Miami Miller School of Medicine

1600 Northwest 10th Avenue, Miami, FL, USA 33136


The information you provide is confidential and is never sold or shared with outside vendors. By clicking the button, you agree to the PatientWing's Terms and Privacy Policy.